Nephrogenic Systemic Fibrosis

Jeffrey C. Weinreb, Phillip H. Kuo

Research output: Contribution to journalReview articlepeer-review

26 Scopus citations

Abstract

There seems to be an association between exposure to intravenous gadolinium-based contrast agents (GBCAs) and nephrogenic systemic fibrosis (NSF), a debilitating and sometimes fatal disease. This article addresses the relationship between GBCAs and NSF and answers some common questions. The policy deployed at Yale-New Haven Hospital for prevention of NSF and screening for patients at risk is delineated and discussed along with recommendations by the Food and Drug Administration.

Original languageEnglish (US)
Pages (from-to)159-167
Number of pages9
JournalMagnetic resonance imaging clinics of North America
Volume17
Issue number1
DOIs
StatePublished - Feb 1 2009

Keywords

  • Gadolinium
  • Gadolinium chelates
  • Gadolinium-based contrast agent
  • MR contrast agents
  • MR imaging
  • Nephrogenic systemic fibrosis

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'Nephrogenic Systemic Fibrosis'. Together they form a unique fingerprint.

Cite this